The organisation for the 24th joint meeting held by kConFab, ISK, ABCFS, ACCFS, Lifepool and the Family Cancer Clinics of Australia for August - September 2023 is progressing well and we will hold a face-to-face and on-line meeting.

Although the named consortia are funded in very different ways and have no official connections, all groups share a common interest in familial and population based cancer. For example, kConFab recruits families at high genetic risk of breast, ovarian and prostate cancer through Family Cancer Clinics located in every State and Territory of Australia and return our research generated germ-line mutation test results back to family members and the relevant treating FCC. In one sense kConFab is the research arm of the national Family Cancer Clinics. Many of the consortia members are health professionals (medical oncologists, surgeons, genetic counsellors, cancer specialists, research scientists) working in the Family Cancer Clinics and major research institutions through-out Australia and New Zealand.

A joint annual meeting has particular value for the groups mentioned as it provides a forum to develop and discuss new research findings, clinical trials and implementation of technologies about families with multiple cases of breast, ovarian, prostate, endometrial melanoma, sarcoma, leukaemia and colorectal cancers.

 

FAC 2023 will be delivered in a hybrid format, combining an in-person conference experience with an online component.

In-Person attendees will experience all the usual highlights of the FAC meeting, including leading keynote presentations, opportunity to submit abstracts to present an oral or poster presentation, opportunity to attend breakout sessions, networking opportunities and an industry exhibition.

Virtual attendees will be able to view the live-streamed presentations in the plenary sessions and participate in the Q & A. They also have the opportunity to submit abstracts and present an oral or poster presentation.

• Genotype-directed therapy and risk mitigation

• Psychosocial aspects of genetic counselling

• Variant curation, case examples, current research and guidelines.

• Haematological malignancies

• Breast, ovarian, prostate, sarcoma, colorectal cancer, haematological malignancies, paediatric cancer susceptibility/predisposition

• Polygenic Risk Score and cancer risk

• Cancer signatures to direct treatment

• The value of surveillance in changing clinical practice

• Early cancer detection research programs

• Imaging biomarkers of breast cancer risk and response to treatment

• Variant curation and bioinformatics 

Invited Speakers

Kelly Bolton. Washington University, St. Louis, USA

Jennifer Brooks. University of Toronto, Canada (via Zoom)

Kristy Brown, Weill Cornell Medicine , USA

Deborah Cragun, University of South Florida, USA

Catherine Goudie, McGill University, Canada (via Zoom)

Uri Tabori , The Hospital for Sick Children , Canada

Richarda de Voer, Radboud University Medical Center, The Netherlands (via Zoom)

Terri McVeigh, The Royal Marsden NHS Foundation Trust

Daniel Buchanan, The University of Melbourne

Lisa Devereux, The Peter MacCallum Cancer Centre, Melbourne

Jessica Duffy, Wollongong Hospital, NSW

John Hopper, The University of Melbourne

Shuai Li, The University of Melbourne, Melbourne
 

Tu Ngugen Dumont, Monash University, Melbourne

Sarah O'Sullivan, Genetic Services of Western Australia

Melissa Southey, Monash University, Melbourne

Heather Thorne, The Peter MacCallum Cancer Centre, Melbourne

Rachel Williams, Prince of Wales Hospital, Sydney

Milita Zaheed, Prince of Wales Hospital, Sydney

©2023 Familial Aspects of Cancer Research & Practice Conference 2023. All Rights Reserved.